Xilio Therapeutics, Inc. (XLO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading XLO…

Xilio Therapeutics, Inc. (XLO) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Xilio Therapeutics, Inc.

XLO · CIK 1840233

4 · Oct 2, 2026 · CHIEF MEDICAL OFFICER Houvras Yariv was granted 105K Stock Option (right to buy)

4

CHIEF MEDICAL OFFICER Houvras Yariv was granted 105K Stock Option (right to buy)

Filed: Oct 2, 2026
Period: Oct 1, 2026
Accession: 0001193125-26-412466
Filer: Xilio Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov